Development

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.

How modern process analytical technologies such as Raman spectroscopy can improve quality control

Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success

Next generation sequencing has unprecedented power in biology, but has yet to reach its full potential in medicine

How the adoption of AI and data-driven techniques can increase efficiencies in pharma manufacturing

The agency is facing a busy year, with potential novel drug approvals ranging from gene therapies to RSV jabs

The field is in need of more detailed product understanding to increase product safety without sacrificing efficacy

How modern chromatography data systems can help mitigate disruption

Research into nanomaterials has opened the door to new therapeutic strategies

How reducing technology-addressable vaccine barriers affects coverage rates